Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4248
Source ID: NCT06293417
Associated Drug: Ezetimibe/Fenofibrate (Ezefeno) And Moderate-Intensity Statin
Title: To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Acronym: ENSEMBLE
Status: RECRUITING
Study Results: NO
Results:
Conditions: T2DM (Type 2 Diabetes Mellitus)|Dyslipidemias
Interventions: DRUG: Ezetimibe/fenofibrate (Ezefeno) and moderate-intensity statin|DRUG: Dose escalation of moderate-intensity statin
Outcome Measures: Primary: major adverse cardiovascular events and diabetic microvascular events for 48 months, major adverse cardiovascular events and diabetic microvascular events for 48 months, 48month from baseline | Secondary: proportion of patients achieving Non-HDL-C less than 100mg/dL, proportion of patients achieving Non-HDL-C less than 100mg/dL, 48month from baseline|proportion of patients achieving LDL less than 70mg/dL, proportion of patients achieving LDL less than 70mg/dL, 48month from baseline|change in Non-HDL-C at 48month from baseline, change in Non-HDL-C at 48month from baseline, 48month from baseline|change in LDL at 48month from baseline, change in LDL at 48month from baseline, 48month from baseline|change in HDL-C at 48month from baseline, change in HDL-C at 48month from baseline, 48month from baseline|change in TG at 48month from baseline, change in TG at 48month from baseline, 48month from baseline|change in LDL-C/HDL-C ratio at 48month from baseline, change in LDL-C/HDL-C ratio at 48month from baseline, 48month from baseline|change in TC/HDL-C ratio at 48month from baseline, change in TC/HDL-C ratio at 48month from baseline, 48month from baseline
Sponsor/Collaborators: Sponsor: Korea University Anam Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 3958
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-03-01
Completion Date: 2027-02-01
Results First Posted:
Last Update Posted: 2024-08-27
Locations: Korea University Anam Hospital, Seoul, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT06293417